Clinical Trials Directory

Trials / Completed

CompletedNCT05476588

Tobacco, Alcohol, Prescription Drug, and Illicit Substance Use- Electronic Spanish Platform

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
1,000 (actual)
Sponsor
Baylor Research Institute · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Accepted

Summary

The goal of this study is to validate the TAPS-ESP as a screen and assessment that can be used in primary care for the screening and treatment of substance use.

Detailed description

This Phase II study seeks to conduct further research to validate the TAPS-ESP as a Spanish language version of the screening and brief assessment and pave the way for its broad dissemination in the healthcare system. The investigators will use a novel application of a Type 1 hybrid effectiveness-implementation design, adapted to a screening validation study. The investigators will conduct a large-scale study to validate the TAPS-ESP against established diagnostic and biomarker metrics, replicating the design of the seminal English-language TAPS study.

Conditions

Interventions

TypeNameDescription
OTHERScreeningScreening and validation of assessment tool translated into Spanish

Timeline

Start date
2022-07-15
Primary completion
2024-03-14
Completion
2024-03-14
First posted
2022-07-27
Last updated
2026-01-26

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT05476588. Inclusion in this directory is not an endorsement.